Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Abbott Laboratories (NYSE:ABT)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials | Reports
Recent Events
Aug 15Dividend payment of $0.21
Location
100 Abbott Park Road
Abbott Park, IL 60064
Phone: (847) 937-6100
Fax: (847) 937-1511
Employees (last reported count): 60,571
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Major Drugs
Company Websites
 ·Home Page
 ·Investor Relations
 ·Employment
 ·Subsidiaries
 ·Divisions
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Index Membership
 ·S&P 500
Ownership
·Insider and 5%+ Owners: 7%
·Over the last 6 months:
 · 4 insider sells; 60.0K shares
·Institutional: 55% (59% of float)
(2,160 institutions)
·Net Inst. Buying: 7.26M shares (+0.84%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Abbott Laboratories engages in the discovery, development, manufacture and sale of a broad and diversified line of healthcare products and services. Abbott has five business segments: Pharmaceutical Products, Diagnostic Products, Hospital Products, Ross Products and International. Abbott also owns 50% of a joint venture, TAP Pharmaceutical Products Inc. On December 15, 2000, Abbott announced that it has a definitive agreement with BASF, A.G. to acquire the pharmaceutical business of BASF, which includes the global pharmaceutical operations of Knoll.
More from Market Guide: Expanded Business Description

Financial Summary
ABT is engaged in the discovery, development, manufacture and sale of a broad line of health care products and services, including diagnostic, pharmaceutical and hospital products. For the six months ended 6/01, sales rose 14% to $7.66 billion. Net income fell 78% to $305.4 million. Revenues reflect higher unit sales in the Hospital and Pharmaceutical segments. Earnings suffered from a $1.19 billion charge for the acquisition of the pharmaceutical business of BASF.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Miles White, 45
Chairman and Chief Exec. Officers
$3.3M$230K
Thomas Freyman, 46
CFO, Sr. VP
--  --  
Jeffrey Leiden, M.D., Ph.D., 45
Exec. VP of Pharmaceuticals and CHief Scientific Officer, Director
--  --  
Richard Gonzalez, 47
Exec. VP, Medical Products
1.8M716K
Jose De Lasa, 59
Sr. VP, Sec. and Gen. Counsel
--  --  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NYSE:ABTAs of 31-Aug-2001
Price and Volume
52-Week Low
on 6-Sep-2000
$41.75 
Recent Price$49.70 
52-Week High
on 30-Nov-2000
$56.25 
Beta0.49 
Daily Volume (3-month avg)3.18M
Daily Volume (10-day avg)2.47M
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change+14.9%
52-Week Change
relative to S&P500
+54.2%
Share-Related Items
Market Capitalization$77.1B
Shares Outstanding1.55B
Float1.44B
Dividends & Splits
Annual Dividend (indicated)$0.84 
Dividend Yield1.69%
Last Split: 2 for 1 on 1-June-1998
Per-Share Data
Book Value (mrq)$5.52 
Earnings (ttm)$1.09 
Earnings (mrq)$0.34 
Sales (ttm)$9.39 
Cash (mrq)$0.57 
Valuation Ratios
Price/Book (mrq)9.01 
Price/Earnings (ttm)45.60 
Price/Sales (ttm)5.29 
Income Statements
Sales (ttm)$14.7B
EBITDA (ttm)$3.08B
Income available to common (ttm)$1.71B
Profitability
Profit Margin (ttm)11.7%
Operating Margin (ttm)14.6%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)9.59%
Return on Equity (ttm)20.53%
Financial Strength
Current Ratio (mrq)1.07 
Debt/Equity (mrq)0.88 
Total Cash (mrq)$884.8M
Short Interest
As of 8-Aug-2001
Shares Short12.0M
Percent of Float0.8%
Shares Short
(Prior Month)
8.72M
Short Ratio3.75 
Daily Volume3.19M
See Profile Help for a description of each item above;   K = thousands;   M = millions;   B = billions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.